Literature DB >> 22577036

Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.

Uta E Höpken1, Armin Rehm.   

Abstract

The interaction between lymphoid tumor cells and their tissue microenvironment is thought to promote dissemination and progression of lymphoma. Those type of interactions consists of at least three cornerstones, among them mesenchymal- or bone marrow-derived stromal cells, cells of the innate or adaptive immune response, and the lymphoma cells themselves. The molecular pathways of crosstalk between the lymphoma cells and their nursing stroma are not well understood and their dissection is challenging because of (1) the complexity of stroma cell subpopulations, (2) kinetic and developmental transitions/switches of stroma composition, and (3) inherent technical difficulties to isolate and analyze defined stroma cell subsets. However, recent studies of bone marrow stroma interaction with leukemia or lymphoma cells have revealed therapeutic targets involved in regulating tumor cell mobilization. Release of tumor cells from their supportive niches could be effectuated by inhibition of homing and retention signals. The present review focuses on the effects of homing receptors and cytokines attributed to lymphoid tissue formation in tumor-stroma interactions within secondary lymphoid tissues. We discuss possible cellular and molecular mechanisms of lymphoma-stroma crosstalk and highlight novel therapeutic strategies based on the disruption of tumor-stroma interaction in secondary lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577036     DOI: 10.1007/s00109-012-0906-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  83 in total

1.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Cell adhesion receptors in lymphoma dissemination.

Authors:  P Drillenburg; S T Pals
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

3.  Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation.

Authors:  Chris G Mueller; Charlotte Boix; Wing-Hong Kwan; Cécile Daussy; Emilie Fournier; Wolf H Fridman; Thierry J Molina
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

4.  Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists.

Authors:  Yanping Hu; Matthew Gale; Jacqueline Shields; Carrie Garron; Mark Swistak; Tri-Hung Nguyen; Gary Jacques; Robert Fogle; William Siders; Johanne Kaplan
Journal:  Leuk Lymphoma       Date:  2011-08-18

Review 5.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

6.  Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas.

Authors:  Livio Trentin; Anna Cabrelle; Monica Facco; Davide Carollo; Marta Miorin; Alicia Tosoni; Paola Pizzo; Gianni Binotto; Linda Nicolardi; Renato Zambello; Fausto Adami; Carlo Agostini; Gianpietro Semenzato
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

7.  CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia.

Authors:  Silvia Buonamici; Thomas Trimarchi; Maria Grazia Ruocco; Linsey Reavie; Severine Cathelin; Brenton G Mar; Apostolos Klinakis; Yevgeniy Lukyanov; Jen-Chieh Tseng; Filiz Sen; Eric Gehrie; Mengling Li; Elizabeth Newcomb; Jiri Zavadil; Daniel Meruelo; Martin Lipp; Sherif Ibrahim; Argiris Efstratiadis; David Zagzag; Jonathan S Bromberg; Michael L Dustin; Iannis Aifantis
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

8.  Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.

Authors:  Kirsteen H Maclean; Frank C Dorsey; John L Cleveland; Michael B Kastan
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.

Authors:  Sonia López-Giral; Nuria E Quintana; María Cabrerizo; Manuel Alfonso-Pérez; Mónica Sala-Valdés; Valle Gómez Garcia De Soria; José María Fernández-Rañada; Elena Fernández-Ruiz; Cecilia Muñoz
Journal:  J Leukoc Biol       Date:  2004-05-20       Impact factor: 4.962

10.  A lymphotoxin-driven pathway to hepatocellular carcinoma.

Authors:  Johannes Haybaeck; Nicolas Zeller; Monika Julia Wolf; Achim Weber; Ulrich Wagner; Michael Odo Kurrer; Juliane Bremer; Giandomenica Iezzi; Rolf Graf; Pierre-Alain Clavien; Robert Thimme; Hubert Blum; Sergei A Nedospasov; Kurt Zatloukal; Muhammad Ramzan; Sandra Ciesek; Thomas Pietschmann; Patrice N Marche; Michael Karin; Manfred Kopf; Jeffrey L Browning; Adriano Aguzzi; Mathias Heikenwalder
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

View more
  10 in total

1.  The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survival.

Authors:  Vanessa Stache; Lydia Verlaat; Marcel Gätjen; Kristina Heinig; Jörg Westermann; Armin Rehm; Uta E Höpken
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

2.  Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.

Authors:  Jiaxiu Ma; Jiapei Jin; Huishuang Lu; Jin Zhang; Yalan Li; Xuefei Cai
Journal:  Front Mol Biosci       Date:  2022-06-13

3.  Isolation and Characterization of a Murine Spontaneous High-Grade Follicular Lymphoma with Restricted In Vivo Spreading--a Model for Lymphatic Metastasis Via the Mesentery.

Authors:  Dóra Vojkovics; Zoltán Kellermayer; Diána Heidt; Martina Mihalj; Béla Kajtár; Dávid Ernszt; Tamás Kovács; Péter Németh; Péter Balogh
Journal:  Pathol Oncol Res       Date:  2015-11-19       Impact factor: 3.201

4.  Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrins.

Authors:  Stephen Middle; Sarah E Coupland; Azzam Taktak; Victoria Kidgell; Joseph R Slupsky; Andrew R Pettitt; Kathleen J Till
Journal:  Exp Hematol Oncol       Date:  2015-04-01

5.  Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model.

Authors:  Pauline Floch; Amandine Marine Laur; Victoria Korolik; Delphine Chrisment; David Cappellen; Yamina Idrissi; Pierre Dubus; Francis Mégraud; Philippe Lehours
Journal:  Oncotarget       Date:  2015-10-27

6.  CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cells.

Authors:  Mario Bunse; Janina Pfeilschifter; Julia Bluhm; Maria Zschummel; Jara J Joedicke; Anthea Wirges; Helen Stark; Vivien Kretschmer; Markus Chmielewski; Wolfgang Uckert; Hinrich Abken; Jörg Westermann; Armin Rehm; Uta E Höpken
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

Review 7.  Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.

Authors:  Carlos Cuesta-Mateos; Jennifer R Brown; Fernando Terrón; Cecilia Muñoz-Calleja
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

8.  Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.

Authors:  Carlos Cuesta-Mateos; Raquel Juárez-Sánchez; Tamara Mateu-Albero; Javier Loscertales; Wim Mol; Fernando Terrón; Cecilia Muñoz-Calleja
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 9.  Underlying mechanisms and drug intervention strategies for the tumour microenvironment.

Authors:  Haoze Li; Lihong Zhou; Jing Zhou; Qi Li; Qing Ji
Journal:  J Exp Clin Cancer Res       Date:  2021-03-15

10.  Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma.

Authors:  Beatriz Somovilla-Crespo; Manuel Alfonso-Pérez; Carlos Cuesta-Mateos; Cristina Carballo-de Dios; Amada E Beltrán; Fernando Terrón; Juan J Pérez-Villar; Carlos Gamallo-Amat; Gema Pérez-Chacón; Elena Fernández-Ruiz; Juan M Zapata; Cecilia Muñoz-Calleja
Journal:  J Hematol Oncol       Date:  2013-12-04       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.